SUPPLY CHAIN

Sustainability takes centre stage for Tower Cold Chain at LogiPharma

Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure, in today’s sustainably inclined world. Visitors...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Shift to consumer-first mindset is highest priority for digital pharma products going into 2023

The new report from Graphite Digital – Overcoming Contradictions – reveals that moving to a consumer-first mindset when it comes to digital products is...

Peli BioThermal launches Crēdo™ Go cold chain shipping solution

Peli BioThermal, the life science industry’s partner from discovery to distribution, announces its newest reusable, flexible temperature controlled shipping solution. Crēdo™ Go is designed...

ACG to launch German process laboratory in 2023

Following the success of its first-to-market laboratory for process development in India, ACG (the world’s biggest integrated pharmaceutical and nutraceutical manufacturing solutions provider), is...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Sustainability takes centre stage for Tower Cold Chain at LogiPharma

Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure,...

86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in next 12 months

86% of pharma and biotech companies say they plan to become more digitally agile, according to a new survey of 100 senior pharmaceutical executives. The...

ADVANZ PHARMA enters into exclusive agreement with Alvotech to commercialise a proposed biosimilar to Xolair

ADVANZ PHARMA has entered into an exclusive agreement with Alvotech for the exclusive license and supply rights for a proposed biosimilar to Xolair (omalizumab). Alvotech...

ACG: “The global pharmaceutical solutions company on a mission to help manufacturers keep their supply chains moving”

The current crisis in Europe has led to increasing energy insecurity and shortages of raw materials, which are creating severe pharmaceutical manufacturing supply line...

Approvals

Takeda’s dengue vaccine approved in Brazil

Takeda's dengue vaccine, QDENGA (Dengue Tetravalent Vaccine ) (TAK-003), has been approved in Brazil by the National Health Surveillance Agency (ANVISA) for the prevention of...

Acadia Pharmaceuticals receives U.S. FDA approval for Rett syndrome treatment

The U.S. Food and Drug Administration (FDA) has approved Acadia Pharmaceuticals' DAYBUE (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients...

Pfizer’s migraine nasal spray receives FDA approval

Bristol Myers Squibb receives European Commission approval of Reblozyl for anemia in adult patients with non-transfusion-dependent beta thalassemia

Reata Pharmaceuticals’ SKYCLARYS approved by FDA for Friedreich’s ataxia

Kevzara approved by U.S. FDA for patients with polymyalgia rheumatica

Manufacturiung

Finance

Research & Development
Latest

R&D

Predictive Oncology and Cancer Research Horizons partner to pursue development of cancer drugs

Predictive Oncology together with Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder of cancer research, Cancer Research...
R&D

Aitia and UCB form strategic drug discovery collaboration in Huntington’s disease

UCB, a global biopharmaceutical company, and Aitia, a leader in the application of Causal AI and “Digital Twins” to discover and develop new drugs,...
R&D

Revolutionary new bone cancer drug could save children’s lives

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia...
R&D

ModeX Therapeutics enters into exclusive worldwide license and collaboration agreement with Merck to develop Epstein-Barr virus vaccine candidate

OPKO Health's ModeX Therapeutics has entered into an exclusive worldwide license and collaboration agreement with Merck, known as MSD outside the United States and...
R&D

Cancer Research UK signs multi-project collaboration with UCB to develop antibody drugs

Cancer Research UK and UCB, a global biopharmaceutical company, have formed a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks